1. US - Rheumatoid Arthritis Drugs Market Overview

  1.1 Current Market Scenario

  1.2 Rheumatoid Arthritis Prevalence and Statistics

  1.3 US Rheumatoid Arthritis Drugs Clinical Trials  Insight

2. US: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Rheumatoid Arthritis – Branded and Generic Availability, Dosage, Patent and Price Analysis

  2.1 Meloxicam (Mobic)

  2.2 Ketoprofen

  2.3 Diflunisal

  2.4 Fenoprofen

  2.5 Flurbiprofen

  2.6 Meclofenamate

  2.7 Tolmetin

  2.8 Etodolac

  2.9 Nabumetone (Relafen)

  2.10 Indomethacin

  2.11 Oxaprozin

  2.12 Piroxicam

  2.13 Sulindac

  2.14 Diclofenac / Misoprostol

  2.15 Esomeprazole / Naproxen

  2.16 Famotidine / Ibuprofen

  2.17 Diclofenac

  2.18 Naproxen

  2.19 Ibuprofen

3. US: Salisylates Drugs for Rheumatoid Arthritis - Branded and Generic Availability, Dosage, Patent and Price Analysis

  3.1 Aspirin

  3.2 Salsalate

  3.3 Sulfasalazine (Azulfidine)

4. US: Tetracyclines for Rheumatoid Arthritis - Branded and Generic Availability, Dosage, Patent and Price Analysis

  4.1 Doxycycline

  4.2 Minocycline

  4.3 Tetracycline

5. US: Narcotic Analgesic Drugs for Rheumatoid Arthritis - Branded and Generic Availability, Dosage, Patent and Price Analysis

  5.1 Acetaminophen / Hydrocodone

  5.2 Acetaminophen / Tramadol

6. US: Topical Rubifacient for Rheumatoid Arthritis - Branded and Generic Availability, Dosage, Patent and Price Analysis

  6.1 Methyl Salicylate

  6.2 Camphor / Menthol / Methyl Salicylate

  6.3 Trolamine Salicylate

7. US: Antimetabolites for Rheumatoid Arthritis - Branded and Generic Availability,

  Dosage and Price Analysis

  7.1 Methotrexate 

8. US: Glucocorticoides Drugs for Rheumatoid Arthritis - Branded and Generic Availability, Dosage, Patent and Price Analysis

  8.1 Prednisone

  8.2 Methylprednisolone

  8.3 Triamcinolone (Kenalog-40)

  8.4 Dexamethasone

  8.5 Cortisone

9. US: Quinolines for Rheumatoid Arthritis - Branded and Generic Availability, Dosage and Price Analysis

  9.1 Hydroxychloroquine

10. US: Disease-Modifying Antirheumatic Drugs (DMARDs) – Branded and Generic Availability, Dosage, Patent and Price Analysis

  10.1 Leflunomide

11. US: TNF Inhibitors - Branded and Generic Availability, Dosage, Patent, Price and Sales Analysis

  11.1 Etanercept

  11.2 Abatacept

12. US: Monoclonal Antibody - Branded and Biosimilars Availability, Dosage, Patent, Price and Sales Analysis

  12.1 Adalimumab

  12.2 Tocilizumab

  12.3 Infliximab

  12.4 Rituximab

  12.5 Certolizumab

  12.6 Golimumab

  12.7 Alemtuzumab

  12.8 Sarilumab

  12.9 Canakinumab 

13. US: Statin - Branded and Generic Availability, Dosage, Patent and Price Analysis

  13.1 Atorvastatin

14. US: Immunosuppresants - Branded and Generic Availability, Dosage, Patent and Price Analysis

  14.1 Azathioprine

  14.2 Anakinra

  14.3 Mycophenolate Mofetil

15. US: JAK Inhibitors for Rheumatoid Arthritis - Branded and Generic Availability, Dosage, Price and Sales Analysis

  15.1 Tofacitinib (Xeljanz)

  15.2 Upadacitinib (Rinvoq)

  15.3 Baricitinib (Olumiant)

16. Other Drugs Targeting Rheumatoid Arthritis - Branded and Generic Availability, Dosage, Patent and Price Analysis

  16.1 Cyclophosphamide

  16.2 Cyclosporine

  16.3 Corticotropin

  16.4 Penicillamine

  16.5 Interferon Gamma-1b (Actimmune)

  16.6 Phenytoin

17. Competitive Landscape

  17.1 AbbVie

  17.2 Bayer

  17.3 Bristol Myers Squibb

  17.4 Eli Lilly and Company

  17.5 Genentech

  17.6 Jassen Pharmaceuticals

  17.7 Novartis

  17.8 Pfizer

  17.9 Roche

  17.10 Sanofi

  17.11 Sun Pharma

  17.12 Teva Pharmaceuticals

Figure 1-1: US – Risk of Developing Rheumatoid Arthritis by Gender (%)

Figure 1-2: US – Rheumatoid Arthritis Market Size (US$), 2020 - 2026

Figure 1-3: US – Newly Diagnosed Rheumatoid Arthritis Cases and Total Cases (Million), 2020

Figure 1-4: US – Cases of Rheumatoid Arthritis by Gender (Million), 2020

Figure 1-5: US – Cases of Rheumatoid Arthritis by Gender (%), 2020

Figure 1-6: US – Arthritis Cases by Type (Million), 2020

Figure 1-7: US – Arthritis Cases by Type (%), 2020

Figure 1-8: US – Estimated Arthritis Cases (Million), 2020, 2025 and 2030

Figure 1-9: US – Estimated Rheumatoid Arthritis Cases (Million), 2020, 2025 and 2030

Figure 1-10: US – Rheumatoid Arthritis Cases by Age (Million), 2020

Figure 1-11: US – Cases of Rheumatoid Arthritis by Age (%), 2020

Figure 1-12: US – Number of Rheumatoid Arthritis Drugs Clinical Trials  by Phase , 2021 -2025

Figure 1-13: US – Number of Rheumatoid Arthritis Drugs Clinical Trials  by Drug Class , 2012 -2016

Figure 1-14: US – Number of Rheumatoid Arthritis Drugs Clinical Trials  by Organization , 2021 - 2026

Figure 1-15: US – Number of Rheumatoid Arthritis Drugs Clinical Trials  by Formulation  , 2021 - 2026

Figure 2-1: Mobic– FDA Approval Year by Dosage Form

Figure 2-2: Mobic – Price for Various Supplies of 7.5mg Tablet (US$), February’2021

Figure 2-3: Mobic – Price for 100 Tablet Supplies and Price Per Unit Tablet of 15mg Tablet (US$), February’2021

Figure 2-4: Qmiiz ODT – Price for 100 Tablet Supplies and Price Per Unit Tablet of 7.5mg and 15mg Dose (US$), February’2021

Figure 2-5: Generic Meloxicam – Price for Various Supplies of 7.5mg Tablet (US$), February’2021

Figure 2-6: Generic Meloxicam – Price for Various Supplies of 15mg Tablet (US$), February’2021

Figure 2-7: Meloxicam – Initial and Maintenance Dose (mg/day)

Figure 2-8: Ketoprofen – Price for 100 Capsules Supplies and Price Per Unit Capsule of 25mg (US$), February’2021

Figure 2-9: Ketoprofen – Price for 100 Capsules Supplies and Price Per Unit Capsule of 50mg (US$), February’2021

Figure 2-10: Ketoprofen – Price for 100 Capsules Supplies and Price Per Unit Capsule of 75mg (US$), February’2021

Figure 2-11: Ketoprofen ER – Price for 100 Capsule Supplies and Price Per Unit Capsule of 200mg (US$), February’2021

Figure 2-12: Ketoprofen – Maximum Daily Dose by Dosage Form (mg/day), February’2021

Figure 2-13: Diflunisal – Price for 60 Tablets Supplies and Price Per Unit Tablet of 75mg (US$), February’2021

Figure 2-14: Diflunisal – Price for 100 Tablets Supplies and Price Per Unit Tablet of 75mg (US$), February’2021

Figure 2-15: Diflunisal – Price for 500 Tablets Supplies and Price Per Unit Tablet of 75mg (US$), February’2021

Figure 2-16: Diflunisal – Minimum and Maximum Daily Dose (mg/day), February’2021

Figure 2-17: Diflunisal – Average Cost of Minimum and Maximum Daily Dose (US$), February’2021

Figure 2-18: Nalfon – Price for 100 Tablets Supplies and Price Per Unit Tablet of 600mg (US$), February’2021

Figure 2-19: Generic Fenopofen – Price for 100 Tablets Supplies and Price Per Unit Tablet of 200mg (US$), February’2021

Figure 2-20: Generic Fenopofen – Price for 60 Tablets Supplies and Price Per Unit Tablet of 600mg (US$), February’2021

Figure 2-21: Generic Fenopofen – Price for 100 Capsules Supplies and Price Per Unit Capsule of 600mg (US$), February’2021

Figure 2-22: Fenoprofen – Minimum and Maximum Daily Dose (mg/day), February’2021

Figure 2-23: Flubiprofen – Price for 15 Tablets Supplies and Price Per Unit Tablet of 100mg (US$), February’2021

Figure 2-24: Flubiprofen – Price for 100 Tablets Supplies and Price Per Unit Tablet of 100mg (US$), February’2021

Figure 2-25: Flubiprofen – Price for 500 Tablets Supplies and Price Per Unit Tablet of 100mg (US$), February’2021

Figure 2-26: Flurbiprofen – Minimum and Maximum Daily Dose (mg/day), February’2021

Figure 2-27: Meclofenamate – Price for 100 Capsules Supplies and Price Per Unit Capsule of 50mg (US$), February’2021

Figure 2-28: Meclofenamate – Price for 100 Capsules Supplies and Price Per Unit Capsule of 100mg (US$), February’2021

Figure 2-29: Meclofenamate – Minimum and Maximum Daily Dose (mg/day), February’2021

Figure 2-30: Meclofenamate – Cost of Minimum and Maximum Daily Dose (US$), February’2021

Figure 2-31: Tolmetin – Price for 100 Tablets Supplies and Price Per Unit Tablet of 600mg (US$), February’2021

Figure 2-32: Tolmetin – Price for 100 Tablets Supplies and Price Per Unit Tablet of 400mg (US$), February’2021

Figure 2-33: Tolmetin – Initial Dose and Maintenance Dose for Rheumatoid Arthritis (mg/ day), February’2021

Figure 2-34: Tolmetin – Initial Dose and Maximum Dose for Juvenile Rheumatoid Arthritis (mg/Kg/day), February’2021

Figure 2-35: Etodolac Capsules – Price for 100 Capsules Supplies of Various Dose Regimens (US$), February’2021

Figure 2-36: Etodolac Tablet – Price for Various Supplies of 400mg (US$), February’2021

Figure 2-37: Etodolac Tablet – Price for Various Supplies of 500mg (US$), February’2021

Figure 2-38: Etodolac ER Tablet – Price for Various Supplies of 500mg (US$), February’2021

Figure 2-39: Etodolac ER Tablet – Price for Various Supplies of 600mg (US$), February’2021

Figure 2-40: Etodolac ER Tablet – Price for Various Supplies of 600mg (US$), February’2021

Figure 2-41: Etodolac Tablet – Minimum and Maximum Daily Dose (mg/day)

Figure 2-42: Etodolac ER Tablet – Minimum and Maximum Daily Dose (mg/day)

Figure 2-43: Etodolac Tablet – Minimum and Maximum Daily Dose for Juvenile Rheumatoid Arthritis by Body Weight (mg/day)

Figure 2-44: Relafen – Price for 30 Tablet Supply and Price Per Unit Tablet of 750mg Dose (US$), February’2021

Figure 2-45: Relafen DS – Price for 30 Tablet Supply and Price Per Unit Tablet of 1000mg Dose (US$), February’2021

Figure 2-46: Relafen DS – Price for 60 Tablet Supply and Price Per Unit Tablet of 1000mg Dose (US$), February’2021

Figure 2-47: Generic Nabumetone – Price for Various Supplies of 500mg Dose (US$), February’2021

Figure 2-48: Generic Nabumetone – Price for Various Supplies of 750mg Dose (US$), February’2021

Figure 2-49: Nabumetone – Initial Dose and Maintenance Dose (mg//day), February’2021

Figure 2-50: US - Tivorbex Patent Issue and Expiration Year

Figure 2-51: Indocin – Price for 237ml Supply and Price Per ml of 25mg/5ml Oral Suspension (US$), February’2021

Figure 2-52: Indocin – Price for 30 Suppositories and Price Per Unit of 50mg Suppository (US$), February’2021

Figure 2-53: Tivorbex – Price for 30 Capsules and Price Per Unit of 20mg Capsules (US$), February’2021

Figure 2-54: Generic Indomethacin – Price for 6 Capsules and Price Per Unit of 25mg Capsules (US$), February’2021

Figure 2-55: Generic Indomethacin – Price for 20 Capsules and Price Per Unit of 50mg Capsules (US$), February’2021

Figure 2-56: Generic Indomethacin ER – Price for 30 Capsules and Price Per Unit of 75mg Capsules (US$), February’2021

Figure 2-57: Generic Indomethacin ER – Price for 100 Capsules and Price Per Unit of 75mg Capsules (US$), February’2021

Figure 2-58: Indomethacin Oral – Initial and Maximum Dose (mg/day)

Figure 2-59: Indomethacin Suppository – Initial and Maintenence Dose (mg/day)

Figure 2-60: Daypro – Price for Various Supplies of 600mg Tablet (US$), February’2021

Figure 2-61: Generic Oxaprozin – Price for Various Supplies of 600mg Tablet (US$), February’2021

Figure 2-62: Generic Oxaprozin – Minimum and Maximum Adult Dose (mg/day)

Figure 2-63: Generic Oxaprozin – Pediatric Dose by Body Weight (mg/day)

Figure 2-64: Feldene – FDA Approval and First Generic Approval Year

Figure 2-65: Feldene – Price for 100 Capsules Supply of Various Dose Regimens (US$), February’2021

Figure 2-66: Generic Piroxicam – Price for 100 Capsules Supply of Various Dose Regimens (US$), February’2021

Figure 2-67: Generic Piroxicam – Price for 500 Capsules Supply and Price Per Unit of 20mg Capsules (US$), February’2021

Figure 2-68: Sulindac – Price for Various Supplies of 150mg Tablets (US$), February’2021

Figure 2-69: Sulindac – Price for Various Supplies of 200mg Tablets (US$), February’2021

Figure 2-70: Sulindac – Initial and Maximum Dose (mg/day)

Figure 2-71: Sulindac – Initial and Maximum Daily Treatment Cost (US$), February’2021

Figure 2-72: Arthrotec – FDA Approval and First Generic Approval Year

Figure 2-73: Arthrotec – Price for Various Supplies of 50mg-200mg Tablets (US$), February’2021

Figure 2-74: Arthrotec – Price for 60 Tablets Supply and Price Per Unit of 75mg-200mg Tablets (US$), February’2021

Figure 2-75: Generic Arthrotec – Price for Various Supplies of 50mg-200mg Tablets (US$), February’2021

Figure 2-76: Generic Arthrotec – Price for 60 Tablets Supply and Price Per Unit of 75mg-200mg Tablets (US$), February’2021

Figure 2-77: Arthrotec – Minimum and Maximum Daily Treatment Cost (US$), February’2021

Figure 2-78: US - Vimovo Patent Issue and Expiration Year

Figure 2-79: Vimovo – Price for 60 Tablets Supply of Various Dose Regimens (US$), February’2021

Figure 2-80: Generic Vimovo – Price for 60 Tablets Supply of Various Dose Regimens (US$), February’2021

Figure 2-81: Vimovo – Daily Treatment Cost Using Generic and Branded Tablet (US$), February’2021

Figure 2-82: US - Duexis Patent Issue and Expiration Year

Figure 2-83: Duexis – Price for 90 Tablet Supply and Price Per Unit Tablet (US$), February’2021

Figure 2-84: Diclofenac Capsules – Price for 90 Capsules Supply and Price Per Unit Capsules of 35mg (US$), February’2021

Figure 2-85: Diclofenac Delayed Release Tablet – Price For 100 Tablets of 25mg  (US$), February’2021

Figure 2-86: Diclofenac Delayed Release Tablet – Price for Various Supplies of 50mg  (US$), February’2021

Figure 2-87: Diclofenac Delayed Release Tablet – Price for Various Supplies of 75mg  (US$), February’2021

Figure 2-88: Catafalm – Price for Various Supplies of Oral Tablet 25mg (US$), February’2021

Figure 2-89: Generic Catafalm – Price for Various Supplies of Oral Tablet 25mg (US$), February’2021

Figure 2-90: Naprosyn – FDA Approval and First Generic Approval Year

Figure 2-91: Naprosyn – Price for 473ml Supply and Price per ml of Oral Suspension (US$), February’2021

Figure 2-92: Generic Naprosyn – Price for 473ml Supply and Price per ml of Oral Suspension (US$), February’2021

Figure 2-93: Aleve – Price for Various Supplies of 220mg Capsule (US$), February’2021

Figure 2-94: Generic Aleve Capsules – Price for Various Supplies of 220mg Capsule (US$), February’2021

Figure 2-95: Generic Aleve Tablets – Price for Various Supplies of 220mg Tablet (US$), February’2021

Figure 2-96: EC-Naprosyn – FDA Approval and First Generic Approval Year

Figure 2-97: EC-Naprosyn – Price for Various Supplies of 375mg Tablet (US$), February’2021

Figure 2-98: EC-Naprosyn – Price for Various Supplies of 500mg Tablet (US$), February’2021

Figure 2-99: Naprelan – FDA Approval and First Generic Approval Year

Figure 2-100: Naprelan – Price for 100 Tablets Supply and Price Per Unit of 375mg Tablet (US$), February’2021

Figure 2-101: Naprelan – Price for 30 Tablets Supply and Price Per Unit of 500mg Tablet (US$), February’2021

Figure 2-102: Generic Naprelan – Price for 100 Tablets Supply and Price Per Unit of 375mg Tablet (US$), February’2021

Figure 2-103: Generic Naprelan – Price for 75 Tablets Supply and Price Per Unit of 500mg Tablet (US$), February’2021

Figure 2-104: Naproxen Immediate Release Tablet – Minimum and Maximum Daily Dose (mg/day)

Figure 2-105: Advil – Price for Various Supplies of 200mg Oral Tablet (US$), February’2021

Figure 2-106: Advil Liqui-Gels – Price for 20 Capsules Supply and Price Per Unit Capsule of 200mg (US$), February’2021

Figure 2-107: Advil Children’s – Price for 120ml Supply and Price per ml of Oral Suspension (US$), February’2021

Figure 2-108: Mortin IB – Price for 20 Capsules Supply and Price Per Unit Capsule of 200mg (US$), February’2021

Figure 2-109: Mortin IB – Price for Various Supplies of 200mg Tablet (US$), February’2021

Figure 2-110: Children’s Mortin – Price for 24 Tablets Supply and Price Per Unit Tablet of 100mg (US$), February’2021

Figure 2-111: Neoprofene – FDA Approval and First Generic Approval Year

Figure 2-112: US - Neoprofene Patent Issue and Expiration Year

Figure 2-113: Neoprofene – Price for 6ml Supply and Price Per ml of Intravenous Solution (US$), February’2021

Figure 2-114: Motrin Childrens – Price for 120ml Supply and Price Per ml of Oral Suspension (US$), February’2021

Figure 2-115: Motrin Childrens – Price for 240ml Supply and Price Per ml of Oral Suspension (US$), February’2021

Figure 2-116: US - Caldolor Patent Issue and Expiration Year

Figure 2-117: Caldolor – Price for 200ml Supply and Price Per ml of 100mg/ml Intravenous Solution (US$), February’2021

Figure 2-118: Caldolor – Price for 400ml Supply and Price Per ml of 800mg/200ml Intravenous Solution (US$), February’2021

Figure 2-119: Generic Ibuprofen – Price for 6ml Supply and Price Per ml of 10mg/ml Intravenous Solution (US$), February’2021

Figure 2-120: Generic Ibuprofen – Price for 20 Capsules and Price Per Unit of 200mg Capsules (US$), February’2021

Figure 2-121: Generic Ibuprofen – Price for 15ml Supply and Price Per ml of 50mg/1.25ml Oral Suspension (US$), February’2021

Figure 2-122: Generic Ibuprofen – Price for 150ml Supply and Price Per ml of 100mg/5ml Oral Suspension (US$), February’2021

Figure 2-123: Generic Ibuprofen – Price for 24 Tablets Supply and Price Per Unit of 200mg (US$), February’2021

Figure 2-124: Generic Ibuprofen – Price for 6 Tablets Supply and Price Per Unit of 400mg (US$), February’2021

Figure 2-125: Generic Ibuprofen – Price for 4 Tablets Supply of 600mg and 800mg Tablets (US$), February’2021

Figure 2-126: Generic Ibuprofen – Price for 24 Tablets Supply and Price Per Unit of 100mg Chewable Tablet (US$), February’2021

Figure 2-127: Ibuprofen – Minimum and Maximum Daily Dose (US$), February’2021

Figure 3-1: Bayer Aspirin – Price for Various Supplies of 325mg Tablets (US$), February’2021

Figure 3-2: Ecpirin – Price for Various Supplies of 325mg Delayed Release Tablets (US$), February’2021

Figure 3-3: Generic Aspirin – Price for Various Supplies of 81mg Delayed Release Tablets (US$), February’2021

Figure 3-4: Generic Aspirin – Price for 100 Tablet Supply and Price Per Unit 325mg  Delayed Release Tablets (US$), February’2021

Figure 3-5: Generic Aspirin – Price for 50 Tablet Supply and Price Per Unit 325mg Tablets (US$), February’2021

Figure 3-6: Generic Aspirin – Price for Various Supplies of 325mg Chewable Tablets (US$), February’2021

Figure 3-7: Generic Aspirin – Price for 12 Suppositories Supply of Various Dose Regimen (US$), February’2021

Figure 3-8: Salsalate – Price for Various Supplies of 500mg Tablets (US$), February’2021

Figure 3-9: Salsalate – Price for Various Supplies of 750mg Tablets (US$), February’2021

Figure 3-10: Sulfasalazine – FDA Approval Year by Product

Figure 3-11: Azulfidine – Price for Various Supplies of 500mg Tablets (US$), February’2021

Figure 3-12: Azulfidine EN – Price for Various Supplies of 500mg Tablets (US$), February’2021

Figure 3-13: Generic Azulfidine EN – Price for Various Supplies of 500mg Tablets (US$), February’2021

Figure 3-14: Generic Azulfidine – Price for Various Supplies of 500mg Tablets (US$), February’2021

Figure 3-15: Salfasalazine – Minimum and Maximum Daily Dose (mg/day)

Figure 4-1: US - Patent Approval and Expiration Year by Mayne Pharmaceuticals

Figure 4-2: US - Patent Approval and Expiration Year by Galderma Laboratories

Figure 4-3: US - Patent Approval and Expiration Year by TCD Royalty

Figure 4-4: Doxocycline - Cost of 10 and per Unit Cost of Injectable Powder (US$), February'2021

Figure 4-5: Doxocycline - Cost of 16, 30, 50, 60 and 100 Hyclate 50mg (US$), February'2021

Figure 4-6: Doxocycline - Cost of 50 and 100 Monohydrate 50mg (US$), February'2021

Figure 4-7: Doxocycline - Cost of 60 and 100 Monohydrate 75mg (US$), February'2021

Figure 4-8: Doxocycline - Cost of 60 Capsule by Strength (US$), February'2021

Figure 4-9: Doxycycline - Costs of Supply of 30 Tablets and per Unit Price of Oral Delayed Release Capsule (US$), February'21

Figure 4-10: Doxycycline - Costs of Supply of 60 Tablets by Strength (US$), February'21

Figure 4-11: Doxycycline - Costs of Supply of 120 Tablets and per Unit Price of Hyclate 50mg Tablet  (US$), February'21

Figure 4-12: Doxycycline - Costs of Supply of 100 Tablets and per Unit Price of Hyclate 100mg Tablet  (US$), February'21

Figure 4-13: US - Patent Approval and Expiration Year by Medicis Pharmaceutical Crop

Figure 4-14: US - Patent Approval and Expiration Year by Melinta Therapeutics

Figure 4-15: US - Patent Approval and Expiration Year by Ora Pharma

Figure 4-16: US - Patent Approval and Expiration Year by Vyne Pharmaceuticals

Figure 4-17: Minocycline - Cost of Supply of 30, 60 and 100 Capsules of 50mg (US$), February'2021

Figure 4-18: Minocycline - Cost of Supply of 100 Capsules and per Unit Cost of 75mg Capsule (US$), February'2021

Figure 4-19: Minocycline - Cost of Supply of 14, 20, 30, 50, 60 and 500 Capsules of 75mg Capsule (US$), February'2021

Figure 4-20: Minocycline - Cost of Supply of 90 and 100 Tablets of 50mg (US$), February'2021

Figure 4-21: Minocycline - Cost of Supply of 100 Capsules and per Unit Cost of 75mg Tablet (US$), February'2021

Figure 4-22:  Minocycline - Cost of Supply of 50 and 60 Tablets of 100mg (US$), February'2021

Figure 4-23: Minocycline - Cost of Supply of 30 Tablets of 45mg, 55mg, 65mg and 80mg OraL Tablets (US$), February'2021

Figure 4-24: Minocycline - Cost of Supply of 30 Tablets of 90mg, 105mg, 115mg and 135mg OraL Tablets (US$), February'2021

Figure 4-25: Minocycline - Recommended Capsule Strength by Weight (mg)

Figure 4-26: US - Tetracycline Patent Approval and Expiration Year

Figure 4-27: Tetracycline - Cost of Supply of 100 and per Unit Price of 250mg Tablet (US$), February'2021

Figure 4-28: Tetracycline - Cost of Supply of 100 and per Unit Price of 500mg Tablet (US$), February'2021

Figure 5-1: Norco – Price for 100 Tablets Supply of Various Dose Regimens (US$), February’2021

Figure 5-2: Norco – Price for 500 Tablets Supply and Price Per Unit of 325mg-10mg Tablet (US$), February’2021

Figure 5-3: Lortab – Price for 473ml Supply and Price Per ml of Oral Liquid (US$), February’2021

Figure 5-4: Generic Acetaminophen/hydrocodone – Price for Various Supplies of 108mg-2.5mg/5ml Oral Liquid (US$), February’2021

Figure 5-5: Generic Acetaminophen/hydrocodone – Price for Various Supplies of 108mg-217mg-5mg/10ml Oral Liquid (US$), February’2021

Figure 5-6: Generic Acetaminophen/hydrocodone – Price for 118ml Supply and Price Per ml of  325mg-7.5mg/15ml Oral Solution (US$), February’2021

Figure 5-7: Generic Acetaminophen/hydrocodone – Price for 120ml Supply and Price Per ml of  325mg-10mg/15ml Oral Solution (US$), February’2021

Figure 5-8: Generic Acetaminophen/hydrocodone – Price for 100 Tablets Supply of Various Dose Regimen (US$), February’2021

Figure 5-9: Ultracet – FDA Approval and First Generic Approval Year

Figure 5-10: Ultracet – Price for 100 Tablets Supply and Price Per Unit of 325mg-37.5mg Tablets (US$), February’2021

Figure 5-11: Generic Ultracet – Price for Various Supplies of 325mg-37.5mg Tablets (US$), February’2021

Figure 6-1: Mentholatum Deep Heating – Price for 60ml Supply and Price Per Unit of Topical Lotion (US$), February’2021

Figure 6-2: Generic Methyl Salicylate – Price for 60ml Supply and Price Per Unit of Topical Oil (US$), February’2021

Figure 6-3: Camphor/Menthol/Methyl Salicylate Cream – Price for 57 Gram Generic and Branded Cream (US$), February’2021

Figure 6-4: Trolamine salicylate – FDA Approval Year by Brand

Figure 6-5: Mobisyl Cream – Price for Various Supplies of 10% Cream (US$), February’2021

Figure 6-6: Arthricream – Price for Various Supplies of 10% Cream (US$), February’2021

Figure 7-1: US - FDA Methotrexate Approval Year

Figure 7-2: Methotrexate - Cost of Supply of Intravenous Solution by Brand (US$), February'2021

Figure 7-3: Trexall - Cost of Supply of 30 Tablets by Strength (US$), February'2021

Figure 7-4: Methotrexate - per Unit Cost of Intravenous Powder and Solution (US$), February-2021

Figure 7-5: Methotrexate - Cost of 20, 30, 36 and 100 Oral Tablets (US$), February'2021

Figure 7-6: Methotrexate - Maximum and Minimum Recommended Dose (mg/week)

Figure 8-1: US - Prednisone Patent Approval and Expiration Year

Figure 8-2: Rayos - Cost of Supply of 30 Tablets and per Unit Price of Tablet (US$), February'21

Figure 8-3: Prednisone - Cost of Supply of 30ml, 120ml and 500ml Oral Solution (US$), February'2021

Figure 8-4: Prednisone - Cost of Supply of 100 Tablets by Strength (US$), February'2021

Figure 8-5: Prednisone - Recommended Maximum and Minimum Dose (mg/day)

Figure 8-6: Medrol- Cost of Supply of 100 Tablets by Strength (US$), February'2021

Figure 8-7: Medrol - Cost of Supply of 25 Tablets by Strength (US$), February'2021

Figure 8-8: Medrol - per Unit Cost of Tablet by Strength (US$), February'2021

Figure 8-9: Medrol Dosepak - Cost of Supply of 21 Tablets and per Unit price of 4mg Oral Tablet (US$), February'2021

Figure 8-10: Depo-Medrol - per Unit Cost of Intravenous Solution by Strength (US$), February'2021

Figure 8-11: SoluMedrol - Cost of Supply of Injectable Powder by Strength (US$), February'2021

Figure 8-12: SoluMedrol - Cost of Preservative Free Injectable Powder by Strength (US$), February'2021

Figure 8-13: Methylprednisolone - Cost of 1 unit Injectable Powder by Strength (US$), February'2021

Figure 8-14: Methyprednisolone - Cost of 40mg/ml Injectable Suspension by Strength (US$), February'2021

Figure 8-15: Methyprednisolone - Cost of 80mg/ml Injectable Suspension by Strength (US$), February'2021

Figure 8-16: Methylprednisolone - per Unit Price of Oral Tablet by Strength (US$), February'2021

Figure 8-17: Kenalovg-40 – Price for a Supply of 1ml, 5ml and 10ml Suspension for Injection (US$), February’2021

Figure 8-18: Triamcinolone – Price for a Supply of 1ml, 5ml, 10ml and 25ml Suspension for Injection (US$), February’2021

Figure 8-19: Kenalog-40 – Minimum and Maximum Dose (mg/day), February’2021

Figure 8-20: Kenalog-40 – Initial and Maintenance Dose in Systemic Administration (mg/day), February’2021

Figure 8-21: Kenalog-40 – Minimum and Maximum Dose in Local Administration (mg/day), February’2021

Figure 8-22: Dexamethasone - Cost of Supply of 24ml, 25ml, 30ml, 125ml and 750ml of 4mg/ml Solution (US$), February'2021

Figure 8-23: Dexamethasone - Cost of Supply of 24ml and 25ml of 10mg/ml Preservative Free Solution (US$), February'2021

Figure 8-24: Dexamethasone - Cost of Supply of 24ml and 25ml of 10mg/ml Solution (US$), February'2021

Figure 8-25: Dexamethasone - Cost of Supply of 237ml, 240ml and 500ml Oral Liquid (US$), February'21

Figure 8-26: Dexamethasone - Cost of Supply of 100 Tablets by Strength (US$), February'2021

Figure 8-27: Dexamthasone - Recommended Maximum and Minimum Dose by Disease

Figure 8-28: Cortisone - Cost of Supply of 100 Tablets and per Unit Price (US$), February'2021

Figure 8-29: Cortisone - Recommended Maximum and Minimum Dose (mg/day)

Figure 9-1: Plaquenil - Cost of Supply of 100 Tablets and per Unit Price of 200mg Tablets (US$), February'2021

Figure 9-2: Hydroxychloroquine - Cost of Supply of 50, 100 and 500 Tablets (US$), February'21

Figure 9-3: Hydroxychloroquine - Maximum and Minimum Recommended Dose (mg)

Figure 9-4: Hydroxychloroquine - Recommended Dose (Tablet)

Figure 10-1: US – Leflunomide FDA Approval and Generic Approval Year

Figure 10-2: Arava – Cost of Supply of 30 Tablets and Per Unit Price (US$), February’2021

Figure 10-3: Leflunomide – Cost of Supply of 30, 50 and 1000 Oral 10mg Tablets (US$), February’2021

Figure 10-4: Leflunomide – Cost of Supply of 30, 50 and 1000 Oral 20mg Tablets (US$), February’2021

Figure 10-5: Price Differential of Generic and Braned Oral Tablet by Strength (US$)

Figure 10-6: Leflunomide – Recommended Dose (mg/day) by Phase

Figure 10-7: Leflunomide – Recommended Initial Dose and Reduced Dose (mg/day)

Figure 11-1: US – Etanercept Patent Approval and Expiration Year

Figure 11-2: US – FDA Approval History of Branded Drugs and Biosimilars

Figure 11-3: Etanercept – Cost of Supply of 4 Kits and Per Unit Price (US$), February’2021

Figure 11-4: Etanercept – Cost of Supply of 2ml and Per Unit Price of 25mg/0.5ml Solution (US$), February’2021

Figure 11-5: Etanercept – Cost of Supply of 4ml and Per Unit Price of 50mg/ml Solution (US$), February’2021

Figure 11-6: Etanercept – Cost of Single Cycle, Monthly and Annual Cost by Subcutaneous Kit (US$)

Figure 11-7: Etanercept – Cost of Single Cycle, Monthly and Annual Cost by 25mg/0.5ml Subcutaneous Solution (US$)

Figure 11-8: Etanercept – Cost of Single Cycle, Monthly and Annual Cost by 50mg/ml Subcutaneous Solution (US$)

Figure 11-9: Global – Enbrel Annual Sales (US$ Millions), 2017-2020

Figure 11-10: Global – Enbrel Quaterly Sales (US$ Millions), 2019

Figure 11-11: US – Enbrel Quaterly Sales (US$ Millions), 2019

Figure 11-12: Enbrel - Annual Sales by Region (%), 2019

Figure 11-13: Global – Enbrel Quaterly Sales (US$ Millions), 2020

Figure 11-14: US - Enbrel Quaterly Sales (US$ Millions), 2020

Figure 11-15: Enbrel - Annual Sales by Region (US$ Million), 2020

Figure 11-16: Enbrel - Annual Sales by Region (%), 2020

Figure 11-17: Abatacept – FDA Approval History by Type

Figure 11-18: Abatacept – Recommended Dose by Weight (mg)

Figure 11-19: Abatacept – Required Number of Vials by Weight

Figure 11-20: Abatacept – Average Cost per Cycle by Weight (US$)

Figure 11-21: Global – Abatacept Annual Sales (US$ Million), 2017-2020

Figure 11-22: US – Abatacept Annual Sales (US$ Million), 2017-2020

Figure 11-23: Global – Abatacept Quarterly Sales (US$ Million), 2019 and 2020

Figure 11-24: US - Abatacept Quarterly Sales (US$ Million), 2019 and 2020

Figure 11-25: Abatacept – Annual Sales by Region (%), 2020

Figure 12-1: US – FDA Approval History of Humira and Biosimilar Drugs

Figure 12-2: Humira – Cost of Supply of 2 Kit and Per Unit price (US$), February’2021

Figure 12-3: Humira – Maximum and Minimum Recommended Dose (mg/week)

Figure 12-4: Global – Humira Annual Sales (US$ Million), 2018-2020

Figure 12-5: US - Humira Annual Sales (US$ Million), 2018-2020

Figure 12-6: Global - Humira Quarterly Sales (US$ Million), 2019 and 2020

Figure 12-7: US - Humira Quarterly Sales (US$ Million), 2019 and 2020

Figure 12-8: Humira – Annual Sales by Region (%), 2020

Figure 12-9: Tocilizumab – Cost of Supply of 20ml, 10ml, 4ml and 1ml Intravenous Solution (US$), February’2021

Figure 12-10: Tocilizumab – Cost of Supply of 0.9ml and1ml Subcutaneous Solution (US$), February’2021

Figure 12-11: Tocilizumab – Recommended Maximum and Minimum Dose of Intravenous Solution (mg/kg)

Figure 12-12: Global – Tocilizumab Annual Sales (US$ Million), 2017-2019

Figure 12-13: US - Tocilizumab Annual Sales (US$ Million), 2017-2019

Figure 12-14: US – Tocilizumab Quarterly Sales (US$ Million), 2020

Figure 12-15: Tocilizumab – Annual Sales by Region (US$ Million), 2020

Figure 12-16: Tocilizumab – Annual Sales by Region (%), 2020

Figure 12-17: Remicade – FDA Approval History for Branded and Biosimilars

Figure 12-18: Price Differential of Branded and Biosimilars Intraveous Powder (US$), February’2021

Figure 12-19: Remicade – Recommended Maximm and Minimum Dose (mg/kg)

Figure 12-20: Global – Inflectra Quarterly Sales (US$ Million), 2018 and 2019

Figure 12-21: US – Inflectra Quarterly Sales (US$ Million), 2018 and 2019

Figure 12-22: Inflectra – Annual Sales by Region (%), 2019

Figure 12-23: Global – Inflectra Quarterly Sales (US$ Million), 2020

Figure 12-24: US - Inflectra Quarterly Sales (US$ Million), 2020

Figure 12-25: Inflectra – Annual Sales by Region (%), 2020

Figure 12-26: Global – Inflectra Annual Sales (US$ Million), 2018-2020

Figure 12-27: US - Rituximab, Truxima and Ruxience Approval Year

Figure 12-28: Rituximab – Cost of Supply of 10ml, 50ml and 100ml Intravenous Solution (US$), February’2021

Figure 12-29: Truxima - Cost of Supply of 10ml and 50ml Intravenous Solution (US$), February’2021

Figure 12-30: Ruxience - Cost of Supply of 10ml and 50ml Intravenous Solution (US$), February’2021

Figure 12-31: Average Cost of Per Unit Supply of Rituximab, Truxima and Ruxience (US$), February’2021

Figure 12-32: Riabni - Cost of Supply of 10mg and 500mg Intravenous Solution (US$)

Figure 12-33: Global – Rituximab Annual Sales (US$ Million), 2017-2020

Figure 12-34: US - Rituximab Annual Sales (US$ Million), 2017-2020

Figure 12-35: Rituximab – Annual Sales by Region (%), 2019

Figure 12-36: Rituximab – Annual Sales by Region (%), 2020

Figure 12-37: US – Certolizumab FDA Approval and Patent Exclusivity Year

Figure 12-38: Certolizumab – Cost of Single Cycle and Annual Cost of Treatment (US$)

Figure 12-39: Global – Cimzia Annual Sales (US$ Million), 2017-2019

Figure 12-40: US - Cimzia Annual Sales (US$ Million), 2017-2019

Figure 12-41: Cimzia – Annual Sales by Region (US$ Million), 2019

Figure 12-42: Cimzia – Annual Sales by Region (%), 2019

Figure 12-43: Global – Cimzia Half Yearly Sales (US$ Million), 2016-2019

Figure 12-44: US -  Cimzia Half Yearly Sales (US$ Million), 2016-2019

Figure 12-45: Cimzia – Half Yearly Sales by Region (%), 2020

Figure 12-46: US – FDA Approval History by Brand

Figure 12-47: Simponi – Cost of Supply of 0.5ml and 1ml Subcutaneous Solution, February’2021

Figure 12-48: Simponi Aria – Cost of Supply of 4ml and 1ml Subcutaneous Solution (US$), February’2021

Figure 12-49: Recommended Dose by Drug Type (mg/month)

Figure 12-50: Global - Gloimumab Annual Sales (US$ Million), 2017-2019

Figure 12-51: US – Gloimumab Annual Sales (US$ Million), 2017-2019

Figure 12-52: Global – Golimumab Quarterly Sales (US$ Million), 2019 and 2020

Figure 12-53: US - Golimumab Quarterly Sales (US$ Million), 2019 and 2020

Figure 12-54: Golimumab – Annual Sales by Region (%), 2020

Figure 12-55: US – Alemtuzumab FDA Approval and Patent Exclusivity Year

Figure 12-56: Alemtuzumab – Cost of 1.2ml and 1ml Intravenous Solution (US4), February’2021

Figure 12-57: Sarilumab – Cost of Supply of 2.8ml and 1ml Intravenous Solution, February’2021

Figure 12-58: Sarilumab – Recommended Initial Dose and Reduced Dose (mg)

Figure 12-59: Global - Sarilumab Annual Sales (US$ Million), 2017-2020

Figure 12-60: US – Sarilumab Annual Sales (US$ Million), 2017-2019

Figure 12-61: Global – Sarilumab Quarterly Sales (US$ Million), 2019 and 2020

Figure 12-62: US - Sarilumab Quarterly Sales (US$ Million), 2019 and 2020

Figure 12-63: US – Canakinumab FDA Approval and Patent Exclusivity Year

Figure 12-64: Canakinumab – Maximum and Minimum Recoomended Dose (mg)

Figure 12-65: Canakinumab – Maximum and Minimum Cost of Cycle (US$)

Figure 12-66: Global – Ilaris Annual Sales (US$ Million), 2018-2020

Figure 13-1: US - Atorvastatin Patent Approval and Expiration Year

Figure 13-2: Lipitor – Cost of Supply of 30, 90 and 100 Oral 10mg Tablets (US$), February’2021

Figure 13-3: Lipitor – Cost of Supply of 30, 90 and 100 Oral 20mg and 40mg Tablets (US$), February’2021

Figure 13-4: Lipitor – Cost of Supply of 64, 90 and 500 Oral 80mg Tablets (US$), February’2021

Figure 13-5: Atorvastatin - Cost of Supply of 30, 90 and 100 Oral 10mg Tablets (US$), February’2021

Figure 13-6: Atorvastatin - Cost of Supply of 30, 90 and 100 Oral 20mg Tablets (US$), February’2021

Figure 13-7: Atorvastatin - Cost of Supply of 30, 90 and 100 Oral 40mg Tablets (US$), February’2021

Figure 13-8: Atorvastatin - Cost of Supply of 30, 90 and 100 Oral 80mg Tablets (US$), February’2021

Figure 13-9: Price Differential of Branded and Generic Drug (US$)

Figure 14-1: Azasan – Cost of Supply of 100 Tablets and Per Unit Price of 75mg Tablet (US$), February’2021

Figure 14-2: Azasan – Cost of Supply of 100 Tablets and

Figure 14-3: Imuran – Cost of Supply of 100 Tablets and Per Unit Price of 50mg Tablet (US$), February’2021

Figure 14-4: Azathioprine - Cost of Supply of 30, 50, 100 and 500 Tablets (US$), February’2021

Figure 14-5: Azathioprine – Minimum and Maximum Recommended Dose (mg/kg)

Figure 14-6: US – Anakinra FDA Approval and Patent Exclusivity Year

Figure 14-7: Anakinra – Cost of 4.69ml and 1ml of Intravenous Solution (US$), February’2021

Figure 14-8: Anakinra – Cost of 18.76ml and 1ml of Intravenous Solution (US$), February’2021

Figure 14-9: Anakinra – Average Cost of Single Cycle, Monthly and Annual Cost of Treatment (US$)

Figure 14-10: US – Cellcept Patent Approval and Expiration Year

Figure 14-11: Cellcept – Cost of 4 Intravenous Powder and Unit Cost Oral Powder (US$), February’2021

Figure 14-12: Cellcept – Cost of 160ml Powder and Unit Cost Oral Powder (US$), February’2021

Figure 14-13: Cellcept – Cost of 100 and 500 Oral Capsules (US$), February’2021

Figure 14-14: Cellcept – Cost of 100 and 500 Oral Tablets (US$), February’2021

Figure 14-15: Mycophenolate Mofetil - Cost of 4 Intraveno